Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In

Yael L. Maxwell

November 10, 2016

News Daily News

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Michael O'Riordan

September 30, 2016

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Daily News

Gender Should Not Factor Into DAPT Choice After PCI

L.A. McKeown

August 19, 2016

News Daily News

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Shelley Wood

July 19, 2016

News Daily News

Aspirin App Pairs Clinical Studies With Technology to Balance Bleeding, Benefits

Michael H. Wilson

June 27, 2016

News Conference News AHA 2015

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Yael L. Maxwell

November 09, 2015

News Conference News ESC 2015

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

Caitlin E. Cox

August 31, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Advertisement

Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Gender Should Not Factor Into DAPT Choice After PCI

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Aspirin App Pairs Clinical Studies With Technology to Balance Bleeding, Benefits

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content